Publications by authors named "Morgane Cellier"

Claim this Profile
A
Adverse drug effect in the context of drug shortage: the CIRUPT prospective study from the French pharmacovigilance network.
Delphine Bourneau-Martin, Aurelie Grandvuillemin, Marina Babin, Charlotte Mullet, Hillary Said, Morgane Cellier

Eur J Hosp Pharm· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclopeptide mushroom poisoning: A retrospective series of 204 patients.
Jérémy Lecot, Morgane Cellier, Arnaud Courtois, Dominique Vodovar, Gaël Le Roux

Basic Clin Pharmacol Toxicol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse drug reaction related to drug shortage: A retrospective study on the French National Pharmacovigilance Database.
Delphine Bourneau-Martin, Marina Babin, Aurélie Grandvuillemin, Charlotte Mullet, Francesco Salvo, Morgane Cellier

Br J Clin Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal Safety Profile of BCR-ABL Tyrosine Kinase Inhibitors in a Real-Life Setting: A Study Based on Vigibase, the WHO Pharmacovigilance Database.
Morgane Cellier, Delphine Bourneau-Martin, Chadi Abbara, Alexandre Crosnier, Laurence Lagarce

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: amanitin intoxication.
Morgane Cellier, Jérémy Lecot, Chloe Bruneau, Marie Deguigne, Marc Fadel

Clin Toxicol (Phila)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poisoning exposure from non-pharmaceutical products in residents of structured living facilities.
Marie Deguigne, Morgane Cellier, Yveline Hamon, Marion Legay, Alexis Descatha

Clin Toxicol (Phila)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal Safety Profile of EGFR Targeted Therapies: A Study from VigiBase the WHO Global Database of Individual Case Safety Reports.
Alexandre Crosnier, Chadi Abbara, Morgane Cellier, Laurence Lagarce, Marina Babin

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis